問題一覧
1
Typicals have D2 binding only whereas Atypicals have D2 and 5HT2A binding
2
Atypicals have less EPS/TD, DIP, Prolactin, and they dont worsen negative symptoms
3
There is no difference in efficacy between them
4
Positive symptoms
5
DIP
6
Negative/cognitive/affective symptoms
7
5HT2A antagonism
8
5HT2A antagonism
9
5HT2A antagonism
10
5HT2A antagonist
11
5HT1A
12
Mania
13
Antidepressant actions
14
5HT2C + H1
15
None
16
D2 antagonism
17
H1 antagonism
18
M3 antagonism
19
5HT1A partial agonism
20
5HT2C antagonism
21
They are all sedating and cause weight gain as a class, and work on alpha, H1, and M3 receptors
22
Treatment resistant schizophrenia
23
600 mg per day
24
The potential for an illeus
25
Atropine
26
Clozapine
27
Luvox, because it is a CYP1A2 inhibitor and clozapine is metabolized via CYP1A2 which would cause it to reach dangerous levels
28
Because smoking is an inducer of CYP1A2 which will reduce clozapine levels. When they are admitted to the hospital they will have to quit temporarily and the dose will be decreased, but when they are discharged it is important to increase the dose when they pick up smoking again.
29
Myocarditis, Agranulocytosis, Seizures, Sedation, Sialorrhea, Weight Gain, Constipation, Orthostatic Hypotension
30
> 1500
31
Check ANC weekly for 1st 6 months, then bi-weekly for another 6 months, then every month for the rest of their lives
32
Benzos r/t excess sedation
33
H1, alpha 1, M1, M3; anticholinergic actions, orthostatic hypotension, sedation, and weight gain
34
Sedation = high Weight gain = high EPS = low
35
5HT2C, H1, and M3; Antidepressant actions, weight gain ++, and sedation
36
Lower risk overall but still higher than clozapine
37
5HT2A, 5HT1A, NRI, 5HT2C, H1, M1 and M3, alpha 2; it causes Antidepressant actions, sedation, and weight gain
38
Quetiapine because it has a low risk for EPS
39
Sedation: high Weight gain: high EPS: low
40
50 mg
41
300 mg
42
800 mg
43
Asenapine
44
It tastes bad and can cause numbness and tingling of the mouth and tongue
45
Schizophrenics, Bipolar, and Child/Adolescents
46
5HT2C, 5HT1A, 5HT1B, 5HT1D, 5HT7, alpha 2, and H1; Antidepressant actions, sedation, and weight gain
47
Sedation: high Weight gain: moderate EPS: moderate
48
Ziprasidone (Geodon), Lurasidone (Latuda), Lumateperone (Caplyta)
49
< 6 mg = atypical behavior > 6 mg = typical behavior
50
5HT2A and alpha 1; causes hyperprolactemia, sedation, and orthostatic hypotension
51
Sedation = medium Weight gain = high EPS = high
52
Risk: Hyperprolactemia Benefit: Less sedating
53
5HT2A and alpha 2; hyperprolactemia, low sedation, mood stabilizer
54
It is not metabolized by the liver but extreted in the urine
55
Sedation: moderate Weight gain: moderate EPS: high
56
Because it must be taken with 500 calories of food for a total of 1000 calories per day
57
Prolonged QT
58
5HT2C, 5HT1A, 5HT1B, 5HT1D, 5HT7, alpha 2; Antidepressant effects, low weight gain, low sedation
59
Sedation: moderate Weight gain: low EPS: high
60
Potent alpha 1 antagonism
61
Titrate slowly over several days to avoid orthostatic hypotension
62
Twice a day
63
Iloperidone
64
Lurasidone
65
Sedation: moderate Weight Gain: low EPS: moderate
66
CYP3A4. Inducers: Tegretol, St John's Wort; Inhibitors: Grapefruit
67
Lumateperone
68
EPS: low Prolactin: low Sedation: high
69
Lumateperone
70
Lumateperone
71
Lumateperone
72
High risk of akathesia, but not sedating, low weight gain and prolactin level
73
D2 & 5HT1A partial agonists
74
5HT7, 5HT1A partial agonist; high akathesia, antidepressant actions, low sedation, low weight gain, and low EPS
75
Brexpiprazole
76
5HT7, 5TH1A partial agonist, alpha 1; anxyolitic, antidepressant, low weight gain, low sedation, and moderate EPS
77
Cariprazine
78
High D3 partial agonist and 5HT1A partial agonist; antidepressant actions that can treat negative symptoms of schizophrenia, bipolar mixed features, depression, and substance use. Also has low sedation and weight gain, and moderate EPS.
79
Pimavanserin
80
Pimavanserin or Quetiapine
Patho Renal
Patho Renal
Two Clean Queens · 100問 · 2年前Patho Renal
Patho Renal
100問 • 2年前Pathophysiology
Pathophysiology
Two Clean Queens · 100問 · 2年前Pathophysiology
Pathophysiology
100問 • 2年前Patho Immunology
Patho Immunology
Two Clean Queens · 34問 · 2年前Patho Immunology
Patho Immunology
34問 • 2年前Patho Hematology
Patho Hematology
Two Clean Queens · 100問 · 2年前Patho Hematology
Patho Hematology
100問 • 2年前Patho Hematology 2
Patho Hematology 2
Two Clean Queens · 76問 · 2年前Patho Hematology 2
Patho Hematology 2
76問 • 2年前Patho Respiratory
Patho Respiratory
Two Clean Queens · 100問 · 2年前Patho Respiratory
Patho Respiratory
100問 • 2年前Patho Respiratory 2
Patho Respiratory 2
Two Clean Queens · 54問 · 2年前Patho Respiratory 2
Patho Respiratory 2
54問 • 2年前Patho Cardiovascular
Patho Cardiovascular
Two Clean Queens · 100問 · 2年前Patho Cardiovascular
Patho Cardiovascular
100問 • 2年前Patho Cardiovascular 2
Patho Cardiovascular 2
Two Clean Queens · 56問 · 2年前Patho Cardiovascular 2
Patho Cardiovascular 2
56問 • 2年前Patho MSK
Patho MSK
Two Clean Queens · 52問 · 2年前Patho MSK
Patho MSK
52問 • 2年前Patho Acid Base
Patho Acid Base
Two Clean Queens · 35問 · 2年前Patho Acid Base
Patho Acid Base
35問 • 2年前Renal 2
Renal 2
Two Clean Queens · 10問 · 2年前Renal 2
Renal 2
10問 • 2年前Fluid Balance
Fluid Balance
Two Clean Queens · 43問 · 2年前Fluid Balance
Fluid Balance
43問 • 2年前Patho Endocrine
Patho Endocrine
Two Clean Queens · 100問 · 2年前Patho Endocrine
Patho Endocrine
100問 • 2年前Patho Endocrine 2
Patho Endocrine 2
Two Clean Queens · 42問 · 2年前Patho Endocrine 2
Patho Endocrine 2
42問 • 2年前Infections
Infections
Two Clean Queens · 58問 · 2年前Infections
Infections
58問 • 2年前Patho Shock
Patho Shock
Two Clean Queens · 31問 · 2年前Patho Shock
Patho Shock
31問 • 2年前GI
GI
Two Clean Queens · 100問 · 2年前GI
GI
100問 • 2年前GI 2
GI 2
Two Clean Queens · 18問 · 2年前GI 2
GI 2
18問 • 2年前Cancer
Cancer
Two Clean Queens · 54問 · 2年前Cancer
Cancer
54問 • 2年前問題一覧
1
Typicals have D2 binding only whereas Atypicals have D2 and 5HT2A binding
2
Atypicals have less EPS/TD, DIP, Prolactin, and they dont worsen negative symptoms
3
There is no difference in efficacy between them
4
Positive symptoms
5
DIP
6
Negative/cognitive/affective symptoms
7
5HT2A antagonism
8
5HT2A antagonism
9
5HT2A antagonism
10
5HT2A antagonist
11
5HT1A
12
Mania
13
Antidepressant actions
14
5HT2C + H1
15
None
16
D2 antagonism
17
H1 antagonism
18
M3 antagonism
19
5HT1A partial agonism
20
5HT2C antagonism
21
They are all sedating and cause weight gain as a class, and work on alpha, H1, and M3 receptors
22
Treatment resistant schizophrenia
23
600 mg per day
24
The potential for an illeus
25
Atropine
26
Clozapine
27
Luvox, because it is a CYP1A2 inhibitor and clozapine is metabolized via CYP1A2 which would cause it to reach dangerous levels
28
Because smoking is an inducer of CYP1A2 which will reduce clozapine levels. When they are admitted to the hospital they will have to quit temporarily and the dose will be decreased, but when they are discharged it is important to increase the dose when they pick up smoking again.
29
Myocarditis, Agranulocytosis, Seizures, Sedation, Sialorrhea, Weight Gain, Constipation, Orthostatic Hypotension
30
> 1500
31
Check ANC weekly for 1st 6 months, then bi-weekly for another 6 months, then every month for the rest of their lives
32
Benzos r/t excess sedation
33
H1, alpha 1, M1, M3; anticholinergic actions, orthostatic hypotension, sedation, and weight gain
34
Sedation = high Weight gain = high EPS = low
35
5HT2C, H1, and M3; Antidepressant actions, weight gain ++, and sedation
36
Lower risk overall but still higher than clozapine
37
5HT2A, 5HT1A, NRI, 5HT2C, H1, M1 and M3, alpha 2; it causes Antidepressant actions, sedation, and weight gain
38
Quetiapine because it has a low risk for EPS
39
Sedation: high Weight gain: high EPS: low
40
50 mg
41
300 mg
42
800 mg
43
Asenapine
44
It tastes bad and can cause numbness and tingling of the mouth and tongue
45
Schizophrenics, Bipolar, and Child/Adolescents
46
5HT2C, 5HT1A, 5HT1B, 5HT1D, 5HT7, alpha 2, and H1; Antidepressant actions, sedation, and weight gain
47
Sedation: high Weight gain: moderate EPS: moderate
48
Ziprasidone (Geodon), Lurasidone (Latuda), Lumateperone (Caplyta)
49
< 6 mg = atypical behavior > 6 mg = typical behavior
50
5HT2A and alpha 1; causes hyperprolactemia, sedation, and orthostatic hypotension
51
Sedation = medium Weight gain = high EPS = high
52
Risk: Hyperprolactemia Benefit: Less sedating
53
5HT2A and alpha 2; hyperprolactemia, low sedation, mood stabilizer
54
It is not metabolized by the liver but extreted in the urine
55
Sedation: moderate Weight gain: moderate EPS: high
56
Because it must be taken with 500 calories of food for a total of 1000 calories per day
57
Prolonged QT
58
5HT2C, 5HT1A, 5HT1B, 5HT1D, 5HT7, alpha 2; Antidepressant effects, low weight gain, low sedation
59
Sedation: moderate Weight gain: low EPS: high
60
Potent alpha 1 antagonism
61
Titrate slowly over several days to avoid orthostatic hypotension
62
Twice a day
63
Iloperidone
64
Lurasidone
65
Sedation: moderate Weight Gain: low EPS: moderate
66
CYP3A4. Inducers: Tegretol, St John's Wort; Inhibitors: Grapefruit
67
Lumateperone
68
EPS: low Prolactin: low Sedation: high
69
Lumateperone
70
Lumateperone
71
Lumateperone
72
High risk of akathesia, but not sedating, low weight gain and prolactin level
73
D2 & 5HT1A partial agonists
74
5HT7, 5HT1A partial agonist; high akathesia, antidepressant actions, low sedation, low weight gain, and low EPS
75
Brexpiprazole
76
5HT7, 5TH1A partial agonist, alpha 1; anxyolitic, antidepressant, low weight gain, low sedation, and moderate EPS
77
Cariprazine
78
High D3 partial agonist and 5HT1A partial agonist; antidepressant actions that can treat negative symptoms of schizophrenia, bipolar mixed features, depression, and substance use. Also has low sedation and weight gain, and moderate EPS.
79
Pimavanserin
80
Pimavanserin or Quetiapine